StreetInsider.com News Articles

Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit

Wed, 27 May 2026 08:00:00 -0400

HOUSTON--(BUSINESS WIRE)-- Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces that the Company will present an overview of the ongoing ALSTARS trial, outlining its design and approach to targeting neuroinflammation, at the 5th ALS Drug Development Summit which will take place June 2–4, 2026, in Boston, MA.

The details for the poster presentation, which will be presented by Tyrell Simkins, D.O., Ph.D., Senior Director, Clinical Development, are

Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit

Wed, 27 May 2026 08:00:00 -0400

The details for the poster presentation, which will be presented by Tyrell Simkins, D.O., Ph.D., Senior Director, Clinical Development, are

Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit

Wed, 27 May 2026 08:00:00 -0400

The details for the poster presentation, which will be presented by Tyrell Simkins, D.O., Ph.D., Senior Director, Clinical Development, are

Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit

Wed, 27 May 2026 08:00:00 -0400

The details for the poster presentation, which will be presented by Tyrell Simkins, D.O., Ph.D., Senior Director, Clinical Development, are

Form ARS Coya Therapeutics, Inc. For: Dec 31

Wed, 13 May 2026 08:33:00 -0400

si-local-file:///var/storage/secattach/20260513/26482421.html

Form ARS Coya Therapeutics, Inc. For: Dec 31

Wed, 13 May 2026 08:33:00 -0400

si-local-file:///var/storage/secattach/20260513/26482421.html

Form DEFA14A Coya Therapeutics, Inc.

Wed, 13 May 2026 08:32:00 -0400

si-local-file:///var/storage/secattach/20260513/26482393.html

Form DEFA14A Coya Therapeutics, Inc.

Wed, 13 May 2026 08:32:00 -0400

si-local-file:///var/storage/secattach/20260513/26482393.html

Form DEF 14A Coya Therapeutics, Inc. For: Jun 25

Wed, 13 May 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260513/26482366.html

Form DEF 14A Coya Therapeutics, Inc. For: Jun 25

Wed, 13 May 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260513/26482366.html

Coya Therapeutics, Inc. (COYA) Tops Q1 EPS by 37c

Tue, 12 May 2026 08:59:55 -0400

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q1 EPS of ($0.32), $0.37 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $251.15 million.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

Form 8-K Coya Therapeutics, Inc. For: May 12

Tue, 12 May 2026 08:48:00 -0400

si-local-file:///var/storage/secattach/20260512/26473969.html

Form 8-K Coya Therapeutics, Inc. For: May 12

Tue, 12 May 2026 08:48:00 -0400

si-local-file:///var/storage/secattach/20260512/26473969.html

Form 424B5 Coya Therapeutics, Inc.

Tue, 12 May 2026 08:44:00 -0400

si-local-file:///var/storage/secattach/20260512/26473932.html

Form 424B5 Coya Therapeutics, Inc.

Tue, 12 May 2026 08:44:00 -0400

si-local-file:///var/storage/secattach/20260512/26473932.html

Form 10-Q Coya Therapeutics, Inc. For: Mar 31

Tue, 12 May 2026 07:42:00 -0400

si-local-file:///var/storage/secattach/20260512/26473120.html

Form 10-Q Coya Therapeutics, Inc. For: Mar 31

Tue, 12 May 2026 07:42:00 -0400

si-local-file:///var/storage/secattach/20260512/26473120.html

Form 8-K Coya Therapeutics, Inc. For: May 12

Tue, 12 May 2026 07:39:00 -0400

si-local-file:///var/storage/secattach/20260512/26473110.html

Form 8-K Coya Therapeutics, Inc. For: May 12

Tue, 12 May 2026 07:39:00 -0400

si-local-file:///var/storage/secattach/20260512/26473110.html

Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update